Cargando…
A bibliometric and scientific knowledge map study of the drug therapies for asthma-related study from 1982 to 2021
Objective: Asthma drug research has been increasing yearly, and its clinical application value has increasingly attracted attention. This study aimed to analyze the development status, research hotspots, research frontiers, and future development trends of the research works on drugs for patients wi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574019/ https://www.ncbi.nlm.nih.gov/pubmed/36263119 http://dx.doi.org/10.3389/fphar.2022.916871 |
_version_ | 1784811008752091136 |
---|---|
author | Zhen, Gao Yingying, Liu Weifang, Xu Jingcheng, Dong |
author_facet | Zhen, Gao Yingying, Liu Weifang, Xu Jingcheng, Dong |
author_sort | Zhen, Gao |
collection | PubMed |
description | Objective: Asthma drug research has been increasing yearly, and its clinical application value has increasingly attracted attention. This study aimed to analyze the development status, research hotspots, research frontiers, and future development trends of the research works on drugs for patients with asthma, especially severe asthma. Methods: Asthma drug-related articles published between 1982 and 2021 were retrieved from the Web of Science Core Collection (WOSCC) database, and only articles published in English were included. CiteSpace and VOSviewer software were utilized to conduct collaborative network analysis of countries/regions, institutions, keywords, and co-citation analysis of references. Results: A total of 3,234 asthma drug-related eligible articles were included. The United States was in a leading position, and Karolinska Institute (Sweden) was the most active institution. The most prolific journal in this field was Journal of Asthma, and the most cited journal was Journal of Allergy and Clinical Immunology. Keyword co-occurrence studies suggested that the current hotspots and frontiers were as follows: ① asthma: fully revealing the potential of existing conventional asthma drugs, determining the best drug delivery system, and indicating the best combination. To continue to explore potential targets for severe asthma or other phenotypes. Inhaled glucocorticoids and budesonide are still one of the important aspects of current asthma drug research and ② severe asthma: the research and development of new drugs, especially monoclonal antibodies including omalizumab, mepolizumab, and benralizumab to improve asthma control and drug safety, have become a research hotspot in recent years, highlighting the importance of “target” selection. Conclusion: This study demonstrates the global research hotspots and trends of the research works on drugs for patients with asthma/severe asthma. It can help scholars quickly understand the current status and hotspots of research in this field. |
format | Online Article Text |
id | pubmed-9574019 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95740192022-10-18 A bibliometric and scientific knowledge map study of the drug therapies for asthma-related study from 1982 to 2021 Zhen, Gao Yingying, Liu Weifang, Xu Jingcheng, Dong Front Pharmacol Pharmacology Objective: Asthma drug research has been increasing yearly, and its clinical application value has increasingly attracted attention. This study aimed to analyze the development status, research hotspots, research frontiers, and future development trends of the research works on drugs for patients with asthma, especially severe asthma. Methods: Asthma drug-related articles published between 1982 and 2021 were retrieved from the Web of Science Core Collection (WOSCC) database, and only articles published in English were included. CiteSpace and VOSviewer software were utilized to conduct collaborative network analysis of countries/regions, institutions, keywords, and co-citation analysis of references. Results: A total of 3,234 asthma drug-related eligible articles were included. The United States was in a leading position, and Karolinska Institute (Sweden) was the most active institution. The most prolific journal in this field was Journal of Asthma, and the most cited journal was Journal of Allergy and Clinical Immunology. Keyword co-occurrence studies suggested that the current hotspots and frontiers were as follows: ① asthma: fully revealing the potential of existing conventional asthma drugs, determining the best drug delivery system, and indicating the best combination. To continue to explore potential targets for severe asthma or other phenotypes. Inhaled glucocorticoids and budesonide are still one of the important aspects of current asthma drug research and ② severe asthma: the research and development of new drugs, especially monoclonal antibodies including omalizumab, mepolizumab, and benralizumab to improve asthma control and drug safety, have become a research hotspot in recent years, highlighting the importance of “target” selection. Conclusion: This study demonstrates the global research hotspots and trends of the research works on drugs for patients with asthma/severe asthma. It can help scholars quickly understand the current status and hotspots of research in this field. Frontiers Media S.A. 2022-10-03 /pmc/articles/PMC9574019/ /pubmed/36263119 http://dx.doi.org/10.3389/fphar.2022.916871 Text en Copyright © 2022 Zhen, Yingying, Weifang and Jingcheng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Zhen, Gao Yingying, Liu Weifang, Xu Jingcheng, Dong A bibliometric and scientific knowledge map study of the drug therapies for asthma-related study from 1982 to 2021 |
title | A bibliometric and scientific knowledge map study of the drug therapies for asthma-related study from 1982 to 2021 |
title_full | A bibliometric and scientific knowledge map study of the drug therapies for asthma-related study from 1982 to 2021 |
title_fullStr | A bibliometric and scientific knowledge map study of the drug therapies for asthma-related study from 1982 to 2021 |
title_full_unstemmed | A bibliometric and scientific knowledge map study of the drug therapies for asthma-related study from 1982 to 2021 |
title_short | A bibliometric and scientific knowledge map study of the drug therapies for asthma-related study from 1982 to 2021 |
title_sort | bibliometric and scientific knowledge map study of the drug therapies for asthma-related study from 1982 to 2021 |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574019/ https://www.ncbi.nlm.nih.gov/pubmed/36263119 http://dx.doi.org/10.3389/fphar.2022.916871 |
work_keys_str_mv | AT zhengao abibliometricandscientificknowledgemapstudyofthedrugtherapiesforasthmarelatedstudyfrom1982to2021 AT yingyingliu abibliometricandscientificknowledgemapstudyofthedrugtherapiesforasthmarelatedstudyfrom1982to2021 AT weifangxu abibliometricandscientificknowledgemapstudyofthedrugtherapiesforasthmarelatedstudyfrom1982to2021 AT jingchengdong abibliometricandscientificknowledgemapstudyofthedrugtherapiesforasthmarelatedstudyfrom1982to2021 AT zhengao bibliometricandscientificknowledgemapstudyofthedrugtherapiesforasthmarelatedstudyfrom1982to2021 AT yingyingliu bibliometricandscientificknowledgemapstudyofthedrugtherapiesforasthmarelatedstudyfrom1982to2021 AT weifangxu bibliometricandscientificknowledgemapstudyofthedrugtherapiesforasthmarelatedstudyfrom1982to2021 AT jingchengdong bibliometricandscientificknowledgemapstudyofthedrugtherapiesforasthmarelatedstudyfrom1982to2021 |